Pet Diabetes Care Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Pet Diabetes Care Devices Market Report is Segmented by Drug Type (Insulin Therapy and Oral Medication), Device Type (Glucose Monitoring Devices and Insulin Delivery Devices), Animal Type (Canine and Feline), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Market Size and Forecasts in Value (USD) for the Above Segments.

Pet Diabetes Care Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Pet Diabetes Care Devices Market Size

Pet Diabetes Care Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 2.25 Billion
Market Size (2030) USD 3.04 Billion
CAGR (2025 - 2030) 6.22 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Low

Major Players

Pet Diabetes Care Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Pet Diabetes Care Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Pet Diabetes Care Devices Market Analysis

The Global Pet Diabetes Care Market size is estimated at USD 2.25 billion in 2025, and is expected to reach USD 3.04 billion by 2030, at a CAGR of 6.22% during the forecast period (2025-2030).

The pet diabetes care market has witnessed significant transformation driven by technological advancements in monitoring and treatment solutions. Leading pharmaceutical companies are increasingly focusing on developing innovative products, with recent developments including smart monitoring devices and specialized insulin delivery systems. The integration of digital technology has revolutionized the pet diabetes care devices market, as evidenced by the introduction of mobile applications and tracking devices that enable pet owners to better monitor their pets' conditions. These technological innovations have not only improved treatment efficacy but have also enhanced the overall quality of care available to diabetic pets.


The veterinary healthcare landscape has experienced substantial evolution in terms of treatment protocols and diagnostic capabilities. According to the American Pet Products Association's 2021-2022 National Pet Owners Survey, pet owners are spending significantly on veterinary care, with basic annual expenses for surgical veterinary visits averaging $458 for dogs and $201 for cats. This increasing willingness to invest in pet healthcare has encouraged pharmaceutical companies to expand their research and development efforts in the pet diabetes treatment market, leading to more sophisticated treatment options and improved patient outcomes.


The industry has witnessed notable regulatory developments and strategic initiatives that are reshaping the competitive landscape. The FDA's approval of new diabetes management medications for pets has opened up new treatment possibilities, while collaborative programs between industry stakeholders have enhanced disease awareness and early detection. These partnerships have facilitated better access to diabetes care products and services, while also promoting educational initiatives for pet owners about the importance of regular health monitoring and proper diabetes management.


The market is experiencing a shift toward personalized care approaches and preventive healthcare solutions. Veterinary practices are increasingly adopting comprehensive care models that incorporate regular screening, monitoring, and preventive measures. This trend is supported by the growing availability of specialized diabetes care products and services tailored to different pet species and individual needs. The industry has also seen increased emphasis on professional training and education programs for veterinary practitioners, ensuring better diagnosis and treatment of pet diabetes across various healthcare settings. The pet medical administration market is also evolving to support these comprehensive care models, enhancing the delivery of tailored treatment solutions.

Segment Analysis: By Drug Type

Insulin Therapy Segment in Pet Diabetes Care Market

The insulin therapy segment dominates the global pet diabetes care market, accounting for approximately 92% of the total market share in 2024. This segment's commanding position is primarily driven by insulin being the foundation of diabetes treatment for both diabetic dogs and cats. The segment's strength is attributed to several factors, including the effectiveness of insulin in reducing blood glucose levels by increasing peripheral glucose consumption and suppressing hepatic glucose production. Major products in this segment include Caninsulin/Vetsulin and ProZinc, which are officially registered for veterinary use. The segment's growth is further supported by insulin's crucial role in preventing beta-cell death, prohibiting amyloid deposits in cats, and its effectiveness in controlling various metabolic processes such as adipocyte lipolysis and protein synthesis. Additionally, the segment benefits from continuous product innovations and improvements in insulin delivery systems, making it more convenient for pet owners to manage their pets' diabetes.

Market Analysis of Global Pet Diabetes Care Market: Chart for By Drug Type

Oral Medication Segment in Pet Diabetes Care Market

The oral medication segment represents a smaller but significant portion of the pet diabetes care market. This segment primarily consists of sulfonylurea drugs that enhance insulin release and are specifically used in cats but not in dogs for treating diabetes. The key product in this segment is Glucotrol (glipizide), which works by stimulating additional insulin release from the pancreas to help regulate blood glucose levels. While oral medications provide an alternative treatment option, their effectiveness varies significantly among different animals, with approximately one in eight diabetic cats responding positively to the treatment. The response largely depends on the number of functioning beta cells in the cat's pancreas and its natural insulin production capacity. Despite these limitations, oral medications continue to serve as an important alternative for pets that may not be suitable candidates for insulin therapy.

Segment Analysis: By Device Type

Insulin Delivery Devices Segment in Pet Diabetes Care Market

The insulin delivery devices segment continues to dominate the global pet diabetes care devices market, holding approximately 79% market share in 2024. This significant market position is primarily driven by the widespread use of insulin syringes and pens for administering diabetes medication to pets. The segment's dominance is further strengthened by the increasing adoption of innovative insulin delivery solutions that offer improved accuracy and convenience for pet owners. Major market players like Merck & Co. and Becton, Dickinson and Company have been instrumental in developing advanced insulin delivery systems specifically designed for pets, contributing to the segment's substantial market presence. The growing awareness among veterinarians and pet owners about the importance of proper insulin administration, combined with the rising prevalence of diabetes in pets, particularly in dogs and cats, has further solidified the position of insulin delivery devices as the market leader.

Glucose Monitoring Devices Segment in Pet Diabetes Care Market

The glucose monitoring devices segment is emerging as the fastest-growing segment in the pet diabetes care devices market, projected to grow at approximately 8% CAGR from 2024 to 2029. This accelerated growth is being driven by technological advancements in blood glucose monitoring systems specifically designed for pets, making it easier for owners to track their pets' glucose levels at home. The segment is witnessing increased innovation in terms of user-friendly designs and improved accuracy in readings, which is encouraging more pet owners to adopt these devices for regular monitoring. The rise in demand for continuous glucose monitoring systems for pets, coupled with increasing awareness about the importance of regular blood glucose monitoring in diabetic pets, is fueling the segment's growth. Additionally, veterinary clinics and hospitals are increasingly recommending these devices as essential tools for managing pet diabetes, further contributing to the segment's rapid expansion in the market.

Segment Analysis: By Animal Type

Canine Segment in Pet Diabetes Care Market

The canine segment continues to dominate the global pet diabetes care market, accounting for approximately 55% of the total market share in 2024. This significant market position is primarily driven by the higher prevalence of diabetes in dogs, particularly among middle-aged and older canines between the ages of 5 and 12 years. The segment's dominance is further strengthened by the increasing adoption of dogs as pets worldwide, coupled with growing awareness among pet owners about canine diabetes management. Various dog breeds, including Cocker Spaniels, Dachshunds, Doberman Pinschers, German Shepherds, and Golden Retrievers, are at a greater risk of developing diabetes, which has led to increased demand for diabetes care products and monitoring devices specifically designed for dogs. The rising incidence of obesity in dogs, which is a significant risk factor for diabetes, has also contributed to the segment's market leadership position.

Feline Segment in Pet Diabetes Care Market

The feline segment is emerging as the fastest-growing segment in the pet diabetes care market, projected to grow at a rate of approximately 9% during the forecast period 2024-2029. This accelerated growth is attributed to the increasing awareness about feline diabetes management and the rising adoption of cats as pets, particularly in urban areas. The segment's growth is further fueled by the development of specialized insulin therapies and monitoring devices specifically designed for cats, as their diabetes management requirements differ significantly from dogs. The increasing focus of veterinary pharmaceutical companies on developing feline-specific diabetes treatments and the growing understanding of Type 2 diabetes in cats have also contributed to the segment's rapid expansion. Additionally, the rising prevalence of obesity in cats, which is a major risk factor for diabetes, coupled with the increasing lifespan of domestic cats, is driving the demand for advanced diabetes care solutions in this segment.

Global Pet Diabetes Care Market Geography Segment Analysis

Pet Diabetes Care Market in North America

North America represents the most significant pet diabetes care market globally, driven by high pet ownership rates and advanced veterinary healthcare infrastructure. The United States, Canada, and Mexico comprise this region, with each country showing distinct market characteristics. The region benefits from increased awareness about pet health, sophisticated veterinary facilities, and higher spending capacity on pet healthcare. The presence of major market players and increasing government funding for research and development of pet diabetes care devices market has helped stimulate market growth across the region.

Market Analysis of Global Pet Diabetes Care Market: Forecasted Growth Rate by Region

Pet Diabetes Care Market in the United States

The United States dominates the North American pet diabetes care market, accounting for approximately 83% of the region's market share in 2024. The country maintains its leadership position due to factors such as rising pet adoption rates and increasing per capita animal healthcare expenditure. The presence of sophisticated veterinary infrastructure and growing awareness about pet diabetes management has contributed significantly to market growth. The country has witnessed substantial improvements in diabetes care technologies for pets, with numerous innovative products being introduced regularly. Additionally, the presence of major market players and their focus on research and development has helped maintain the United States' dominant position in the market.

Pet Diabetes Care Market in Canada

Canada emerges as one of the fastest-growing markets in North America, with an expected growth rate of approximately 8% during 2024-2029. The country's market is driven by increasing pet ownership and rising healthcare expenditure on pets. The Canadian market benefits from various government initiatives and campaigns implemented to promote animal health, which are likely to boost the demand for pet diabetes care market in the coming years. The country has also witnessed significant technological advancements in insulin delivery devices, leading to improved health outcomes. The presence of various veterinary organizations and increasing awareness about pet health management continues to drive market growth in the region.

Pet Diabetes Care Market in Europe

Europe represents the second-largest pet diabetes care market globally, with a well-established veterinary healthcare system across the region. The market encompasses key countries including Germany, the United Kingdom, France, Italy, and Spain, each contributing significantly to the regional market growth. The region benefits from high pet ownership rates, advanced healthcare infrastructure, and increasing awareness about pet health management. European countries have shown strong commitment to pet healthcare through various initiatives and regulations supporting animal welfare.

Pet Diabetes Care Market in Germany

Germany leads the European market, commanding approximately 24% of the region's market share in 2024. The country's dominant position is attributed to its high pet ownership rates and sophisticated veterinary healthcare infrastructure. Nearly 45% of all households in Germany own at least one pet, with particularly high ownership rates among families with children. The country's market benefits from the presence of both domestic and international companies, strong distribution networks, and increasing expenditure on pet healthcare.

Pet Diabetes Care Market in Germany

Germany also emerges as the fastest-growing market in Europe, with an expected growth rate of approximately 9% during 2024-2029. The country's rapid growth is driven by increasing adoption rates and rising cases of diabetes among pets. The market is particularly strong in urban areas where pet ownership is high and access to veterinary care is readily available. The presence of advanced healthcare facilities and increasing awareness about pet diabetes management continues to drive market growth in the country.

Pet Diabetes Care Market in Asia-Pacific

The Asia-Pacific region represents a rapidly evolving pet diabetes care market, encompassing key countries such as China, Japan, India, Australia, and South Korea. The region has witnessed significant growth in pet adoption rates, particularly in urban areas, coupled with increasing awareness about pet health management. The market is characterized by improving veterinary healthcare infrastructure and rising disposable incomes, leading to increased spending on pet healthcare.

Pet Diabetes Care Market in China

China leads the Asia-Pacific market, demonstrating strong market presence due to its large pet population and growing awareness about pet healthcare. The country has witnessed a significant increase in pet ownership, particularly in urban areas, with a sophisticated veterinary healthcare infrastructure developing rapidly. The presence of both domestic and international players has created a competitive market environment, leading to improved access to veterinary blood glucose meters market and services.

Pet Diabetes Care Market in China

China also emerges as the fastest-growing market in the Asia-Pacific region, driven by rapid urbanization and increasing pet ownership rates. The country's market growth is supported by rising awareness about pet health management and increasing healthcare expenditure on pets. The competitive landscape includes both domestic and international players, contributing to market expansion through innovative product offerings and improved distribution networks.

Pet Diabetes Care Market in Middle East & Africa

The Middle East & Africa region represents an emerging market for pet diabetes care products, with GCC countries and South Africa as key markets. The region shows varying levels of market development, with GCC countries demonstrating higher pet ownership rates and healthcare spending compared to other areas. GCC emerges as both the largest and fastest-growing market in the region, driven by high disposable incomes and increasing awareness about pet health management. The market benefits from improving veterinary infrastructure and growing pet adoption rates, particularly in urban areas.

Pet Diabetes Care Market in South America

South America represents a growing market for pet diabetes care products, with Brazil and Argentina as key contributing countries. The region demonstrates significant potential due to its large pet population and increasing awareness about pet health management. Brazil emerges as both the largest and fastest-growing market in the region, supported by its substantial pet population and improving veterinary healthcare infrastructure. The market is characterized by the presence of both domestic and international players, contributing to market development through increased product availability and improved distribution networks.

Pet Diabetes Care Devices Industry Overview

Top Companies in Pet Diabetes Care Market

The pet diabetes care market is characterized by companies focusing intensively on product innovation, particularly in insulin delivery systems and glucose monitoring devices. Major players are investing substantially in research and development to introduce advanced therapeutic solutions, with a notable trend toward developing user-friendly devices for pet owners. Companies are expanding their geographical presence through strategic partnerships and distribution agreements, especially in emerging markets where pet adoption rates are rising. Operational excellence is being achieved through vertical integration of manufacturing capabilities and streamlined supply chain management. The competitive landscape shows a clear trend toward digital integration, with companies developing companion apps and monitoring solutions to complement their core product offerings. Strategic moves in the industry are increasingly centered around acquiring complementary technologies and expanding product portfolios through both organic growth and acquisitions.

Consolidated Market Led By Global Players

The pet diabetes care market exhibits a relatively consolidated structure dominated by large pharmaceutical and medical device conglomerates with established animal health divisions. These major players, including Merck, Zoetis, and Boehringer Ingelheim, leverage their extensive research capabilities, global distribution networks, and strong brand recognition to maintain market leadership. The market shows a clear distinction between global players who offer comprehensive product portfolios and smaller specialists focusing on specific therapeutic areas or regional markets. Merger and acquisition activity is primarily driven by large companies seeking to expand their technological capabilities or strengthen their presence in high-growth markets.


The competitive dynamics are shaped by the presence of both pure-play animal health companies and diversified healthcare corporations that maintain significant animal health divisions. Market consolidation continues through strategic acquisitions, particularly targeting companies with innovative technologies or strong regional presence. Local players maintain relevance in specific regions through their understanding of local veterinary practices and established relationships with distributors. The barrier to entry remains high due to substantial requirements for research and development, regulatory compliance, and the need for extensive distribution networks.

Innovation and Market Access Drive Success

Success in the pet diabetes care devices market increasingly depends on companies' ability to develop innovative, user-friendly solutions while maintaining strong relationships with veterinarians and pet owners. Market leaders are focusing on developing integrated care solutions that combine therapeutic products with monitoring devices and digital platforms. Companies must navigate the complex landscape of veterinary relationships, as practitioners significantly influence product adoption and usage. The regulatory environment, while less stringent than human healthcare, requires careful attention to compliance and quality standards, particularly as authorities increase scrutiny of animal health products.


Future competitive advantage will likely stem from companies' ability to provide comprehensive diabetes management solutions rather than standalone products. Successful market participants are investing in educational initiatives for both veterinarians and pet owners, recognizing the importance of awareness in driving product adoption. The threat of substitution remains relatively low due to the specialized nature of diabetes care products, but companies must continue to demonstrate value through improved outcomes and ease of use. Regional expansion strategies need to account for varying levels of veterinary infrastructure and pet owner awareness across markets. Companies entering the market should focus on developing differentiated products or services while building strong distribution partnerships to overcome established player advantages. Additionally, the animal blood glucose meter market is becoming a crucial segment, with innovations in monitoring technologies enhancing the overall diabetes management ecosystem.

Pet Diabetes Care Devices Market Leaders

  1. Merck & Co., Inc.

  2. Zoetis Services LLC

  3. Allison Medical

  4. UltiMed Inc.​

  5. Boehringer Ingelheim

  6. *Disclaimer: Major Players sorted in no particular order
Pet Diabetes Care Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Pet Diabetes Care Devices Market News

  • September 2023: Boehringer Ingelheim received US Food and Drug Administration (FDA) approval for SENVELGO (velagliflozin oral solution), a revolutionary new treatment for cats with diabetes.
  • December 2023: Willows launched a clinic specializing in diabetes mellitus for canines and felines. The clinic's primary goal is to assist both chronic and newly diagnosed diabetic pets, especially in cases where decision-making or clinical progress has proven to be a challenge.

Pet Diabetes Care Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Diabetes and Obesity in Pet Animals
    • 4.2.2 Increase in Pet Adoption
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Diabetes Medications
    • 4.3.2 Adverse Reaction of Medications
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Drug Type
    • 5.1.1 Insulin Therapy
    • 5.1.2 Oral Medication
  • 5.2 By Device Type
    • 5.2.1 Glucose Monitoring Devices
    • 5.2.2 Insulin Delivery Devices
  • 5.3 By Animal Type
    • 5.3.1 Canine
    • 5.3.2 Feline
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Allison Medical
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 Boehringer Ingelheim
    • 6.1.4 Covetrus
    • 6.1.5 Merck & Co. Inc
    • 6.1.6 MED TRUST
    • 6.1.7 Taidoc Technology Corporation
    • 6.1.8 UltiMed Inc.
    • 6.1.9 Zoetis Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Pet Diabetes Care Devices Industry Segmentation

As per the scope of the report, diabetes is a chronic disease that can also affect dogs and cats. Diabetes is more common in older pets, but it can also occur in younger or pregnant pets. The market for pet diabetes care includes therapies for treating or alleviating diabetes in animals, as well as devices for monitoring blood glucose and administering insulin to animals.

The pet diabetes care market is segmented by drug type, device type, animal type, and geography. By drug type, the market is segmented into insulin therapy and oral medication. By device type, the market is segmented into glucose monitoring devices and insulin delivery devices. By animal type, the market is segmented into canine and feline. Geographically, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers market size and forecasts in value (USD) for the above segments.

By Drug Type Insulin Therapy
Oral Medication
By Device Type Glucose Monitoring Devices
Insulin Delivery Devices
By Animal Type Canine
Feline
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Pet Diabetes Care Market Research FAQs

How big is the Global Pet Diabetes Care Market?

The Global Pet Diabetes Care Market size is expected to reach USD 2.25 billion in 2025 and grow at a CAGR of 6.22% to reach USD 3.04 billion by 2030.

What is the current Global Pet Diabetes Care Market size?

In 2025, the Global Pet Diabetes Care Market size is expected to reach USD 2.25 billion.

Who are the key players in Global Pet Diabetes Care Market?

Merck & Co., Inc., Zoetis Services LLC, Allison Medical, UltiMed Inc.​ and Boehringer Ingelheim are the major companies operating in the Global Pet Diabetes Care Market.

Which is the fastest growing region in Global Pet Diabetes Care Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Pet Diabetes Care Market?

In 2025, the North America accounts for the largest market share in Global Pet Diabetes Care Market.

What years does this Global Pet Diabetes Care Market cover, and what was the market size in 2024?

In 2024, the Global Pet Diabetes Care Market size was estimated at USD 2.11 billion. The report covers the Global Pet Diabetes Care Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Pet Diabetes Care Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Global Pet Diabetes Care Market Research

Mordor Intelligence brings extensive expertise to the pet diabetes care market, offering a comprehensive analysis of this rapidly evolving healthcare sector. Our research thoroughly examines the pet diabetes care devices market and related segments. These include veterinary blood glucose meters and pet insulin pen technologies. The report provides detailed insights into pet diabetes treatment options, ranging from diabetic pet treats to advanced monitoring solutions. Coverage extends from major markets to emerging regions, such as Toronto pet diabetes management centers.

The report, available as an easy-to-download PDF, offers stakeholders crucial insights into the pet medical administration landscape and animal blood glucose meter innovations. Our analysis encompasses the entire spectrum of pet care diabetes drugs and their applications. It also examines the growing demand for pet blood glucose meter technologies. Stakeholders benefit from our detailed examination of market dynamics, competitive landscapes, and emerging opportunities across the global pet diabetes care ecosystem. This is supported by comprehensive data and actionable recommendations for business growth.